VASCULAR INVASION IN NON-SMALL-CELL LUNG-CARCINOMA

被引:43
|
作者
ROBERTS, TE
HASLETON, PS
MUSGROVE, C
SWINDELL, R
LAWSON, RAM
机构
[1] WYTHENSHAWE HOSP,DEPT PATHOL,SOUTHMOOR RD,MANCHESTER M23 9LT,LANCS,ENGLAND
[2] UNIV HOSP S MANCHESTER,DEPT MED,MANCHESTER M20 8LR,LANCS,ENGLAND
[3] N STAFFORDSHIRE HOSP,DEPT PATHOL,STOKE ON TRENT,ENGLAND
[4] WYTHENSHAWE HOSP,DEPT THORAC SURG,MANCHESTER M23 9LT,LANCS,ENGLAND
[5] CHRISTIE HOSP,DEPT MED STAT,MANCHESTER,ENGLAND
关键词
D O I
10.1136/jcp.45.7.591
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims:To determine if there is any correlation between vascular invasion and prognosis in non-small cell carcinoma of the lung; and to look specifically at invasion of vascular channels by tumour cells. Methods: Eighty seven patients undergoing lobectomy or pneumonectomy for adenocarcinoma or squamous carcinoma were followed up for five years. The histological sections were studied for evidence of vascular invasion using an elastic van Gieson stain. The incidence of intimal fibrosis in arteries and veins was noted and the proportion with vascular invasion evaluated using a scoring system. The presence or absence of lymphatic permeation and tumour necrosis were noted. Survival data were analysed using the log rank test. Results: The overall five year survival was 32%. There were 64 squamous cell carcinomas and 23 adenocarcinomas. Vascular invasion was seen in 77% of patients and lymphatic invasion in 44%. Neither the presence nor absence nor the proportion of blood vessels showing vascular invasion showed any relation to prognosis. Intimal fibrosis and tumour necrosis were unrelated to prognosis. Patients with lymphatic permeation had recurrence and died earlier than those without. Conclusion: The presence of arterial or venous invasion by adenocarcinoma or squamous carcinoma of the lung was unrelated to survival; lymphatic permeation was associated with poor prognosis. The two common non-small cell lung cancers behaved differently from other solid tumours, where vascular invasion was a significant factor in determination of prognosis. The presence of intimal fibrosis was unrelated to prognosis.
引用
收藏
页码:591 / 593
页数:3
相关论文
共 50 条
  • [41] Crizotinib in the treatment of non-small-cell lung carcinoma
    Pluzanski, Adam
    Piorek, Aleksandra
    Krzakowski, Maciej
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2012, 16 (06): : 480 - 484
  • [42] Cetuximab and biomarkers in non-small-cell lung carcinoma
    Patil, Nitin
    Abba, Mohammed
    Allgayer, Heike
    BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 221 - 231
  • [43] INTEGRIN EXPRESSION IN NON-SMALL-CELL CARCINOMA OF THE LUNG
    SMYTHE, WR
    LEBEL, E
    BAVARIA, JE
    KAISER, LR
    ALBELDA, SM
    CANCER AND METASTASIS REVIEWS, 1995, 14 (03) : 229 - 239
  • [44] PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) EXPRESSION IN FORMALIN-FIXED TISSUE OF NON-SMALL-CELL LUNG-CARCINOMA
    THEUNISSEN, PHMH
    LEERS, MPG
    BOLLEN, ECM
    HISTOPATHOLOGY, 1992, 20 (03) : 251 - 255
  • [45] CHEMOTHERAPY OF METASTATIC NON-SMALL-CELL CARCINOMA OF THE LUNG
    RUCKDESCHEL, JC
    HEMATOLOGICAL ONCOLOGY, 1992, 10 (01) : 25 - 30
  • [46] Pneumopericardium as a non-small-cell lung carcinoma complication
    Kubisa, Anna
    Lesinska, Anna
    Dec, Pawel
    Szewczak-Glodek, Malgorzata
    Kochanowski, Leszek
    Kubisa, Bartosz
    Feledyk, Grzegorz
    Czarnecka, Michalina
    Wojcik, Janusz
    Grodzki, Tomasz
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2016, 13 (03): : 257 - 259
  • [47] PORTable indications in non-small-cell lung carcinoma
    Machtay, Mitchell
    ONCOLOGY-NEW YORK, 2008, 22 (03): : 315 - +
  • [48] Targeted therapy of non-small-cell lung carcinoma
    Tiwari, Divya
    Brodie, Seth A.
    Brandes, Johann C.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2012, 6 (01) : 41 - 56
  • [49] CLINICAL-EVALUATION OF SOLUBLE CYTOKERATIN 19 FRAGMENTS - A NEW MARKER FOR NON-SMALL-CELL LUNG-CARCINOMA
    SUGAMA, Y
    KITAMURA, S
    OHKAWA, J
    OHKUBO, A
    KAWAI, T
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A525 - A525
  • [50] PHASE-II STUDY OF RECOMBINANT BETA INTERFERON IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CARCINOMA
    ETTINGER, DS
    HARWOOD, K
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (01): : 30 - 32